Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINDACT: 70-Gene Signature and Adjuvant Therapy in Breast Cancer
NCT00433589Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Feb 2007
- Primary completion
- Mar 2020
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, capecitabine, letrozole in breast cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Feb 2007; status: completed.
02
Drugs
docetaxelcapecitabineletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00433589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433589.